- Home
- EPAC vs HCM Comparison
EPAC vs HCM Comparison
Compare EPAC & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPAC
- HCM
- Stock Information
- Founded
- EPAC 1910
- HCM 2000
- Country
- EPAC United States
- HCM Hong Kong
- Employees
- EPAC N/A
- HCM N/A
- Industry
- EPAC Industrial Machinery/Components
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- EPAC Technology
- HCM Health Care
- Exchange
- EPAC Nasdaq
- HCM Nasdaq
- Market Cap
- EPAC 2.3B
- HCM 2.5B
- IPO Year
- EPAC N/A
- HCM N/A
- Fundamental
- Price
- EPAC $42.18
- HCM $14.84
- Analyst Decision
- EPAC Buy
- HCM Hold
- Analyst Count
- EPAC 1
- HCM 1
- Target Price
- EPAC $53.00
- HCM $19.00
- AVG Volume (30 Days)
- EPAC 219.6K
- HCM 90.6K
- Earning Date
- EPAC 06-26-2025
- HCM 07-30-2025
- Dividend Yield
- EPAC 0.10%
- HCM N/A
- EPS Growth
- EPAC 35.24
- HCM N/A
- EPS
- EPAC 1.70
- HCM 0.04
- Revenue
- EPAC $599,828,000.00
- HCM $630,201,000.00
- Revenue This Year
- EPAC $5.94
- HCM $14.86
- Revenue Next Year
- EPAC $5.78
- HCM $19.54
- P/E Ratio
- EPAC $24.67
- HCM $66.84
- Revenue Growth
- EPAC 0.43
- HCM N/A
- 52 Week Low
- EPAC $35.18
- HCM $11.51
- 52 Week High
- EPAC $51.91
- HCM $21.50
- Technical
- Relative Strength Index (RSI)
- EPAC 44.97
- HCM 46.89
- Support Level
- EPAC $41.97
- HCM $15.02
- Resistance Level
- EPAC $42.80
- HCM $18.00
- Average True Range (ATR)
- EPAC 0.63
- HCM 0.42
- MACD
- EPAC -0.16
- HCM -0.04
- Stochastic Oscillator
- EPAC 18.72
- HCM 31.45
About EPAC Enerpac Tool Group Corp.
Enerpac Tool Group Corp provides high-precision tools, controlled-force products, and solutions for precise heavy lifting. The company has one reportable segment, the Industrial Tools & Services (IT&S) Segment. The IT&S segment is engaged in the design, manufacture, and distribution of branded hydraulic and mechanical tools and in providing services and tool rental to the refinery/petrochemical; general industrial; industrial maintenance, repair, and operations (MRO); machining & manufacturing; power generation; infrastructure; mining; and other markets. Geographically, the company has operations in Algeria, Australia, Brazil, France, Germany, Kazakhstan, India, Italy, Japan, Norway, Poland, Saudi Arabia, Singapore, South Africa, South Korea, Spain, and the United Arab Emirates.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.